Yuichi Hirose - Concepedia

Author

Yuichi Hirose

Also Known As

H. Sasaki, Hirose Yuichi, Hirose, Y, Hirose, Yuichi, Takashi Matsumoto, Y Hirose, Y. HIROSE, Y. Hirose, Y., Hirose, YUICHI HIROSE

497

Publications

6.7K

Citations

H-Index

184

Concepts

All Affiliations

Fujita Health University Fujita Health University Hospital Keio University University of California, San Francisco Neurological Surgery

About

Yuichi Hirose is an author at Fujita Health University specializing in medicine, neurology, and glioma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	65	2.9K
2	Health Sciences	12	14	321
3	Engineering	8	8	189
4	Natural Sciences	6	6	263
5	Language Studies	1	1	31

Yuichi Hirose

135

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells. Yuichi Hirose, Mitchel S. Berger, Russell O. Pieper PubMed G2/m ArrestApoptosisCell DeathPathologyHigh-grade Gliomas	2001	343
Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. Yukihiko Sonoda, T. Ozawa, Yuichi Hirose, PubMed Glioma FormationNormal Human AstrocytesCerebral OrganoidHuman Malignant GliomasGlioma	2001	281
Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells. Yuichi Hirose, Mitchel S. Berger, Russell O. Pieper PubMed ApoptosisCell DeathTmz-induced MmrChk1-mediated GCancer Biology	2001	236
Akt Activation Suppresses Chk2-Mediated, Methylating Agent–Induced G2 Arrest and Protects from Temozolomide-Induced Mitotic Catastrophe and Cellular Senescence Yuichi Hirose, Makoto Katayama, Olga K. Mirzoeva, Cancer Research ApoptosisCell DeathTemozolomide-treated CellsCancer BiologyGlioma	2005	151
Astroblastoma: Clinicopathologic Features and Chromosomal Abnormalities Defined by Comparative Genomic Hybridization Daniel J. Brat, Yuichi Hirose, Kenneth J. Cohen, Brain Pathology	2000	147
Chromosomal Abnormalities Subdivide Ependymal Tumors into Clinically Relevant Groups Yuichi Hirose, Kenneth Aldape, Andrew W. Bollen, American Journal Of Pathology Lymphoid NeoplasiaMedicinePathologyOncologyCancer Research	2001	141
The p38 Mitogen-Activated Protein Kinase Pathway Links the DNA Mismatch Repair System to the G<sub>2</sub> Checkpoint and to Resistance to Chemotherapeutic DNA-Methylating Agents Yuichi Hirose, Makoto Katayama, David Stokoe, Molecular and Cellular Biology Mmr DeficientImmunologyMolecular BiologyCell DeathCell Cycle	2003	121
Why do chronic subdural hematomas continue to grow slowly and not coagulate? Role of thrombomodulin in the mechanism Hideki Murakami, Yuichi Hirose, Masachika Sagoh, Journal of neurosurgery	2002	120
Oncolytic Virus-Mediated Manipulation of DNA Damage Responses: Synergy With Chemotherapy in Killing Glioblastoma Stem Cells Ryuichi Kanai, Samuel D. Rabkin, Stephen Yip, JNCI Journal of the National Cancer Institute	2011	113
Integrated clinical, histopathological, and molecular data analysis of 190 central nervous system germ cell tumors from the iGCT Consortium Hirokazu Takami, Kohei Fukuoka, Shintaro Fukushima, Neuro-Oncology	2019	109

Page 1